ClinicalTrials.govpublic full text
Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
follicular lymphoma, marginal zone lymphoma, mantle cell lymphoma, chronic lymphocytic lymphoma, b-cell lymphoma, cd47, monoclonal anti-cd20 antibody, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905710
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.